Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Matsuo Y et al. Effect of a novel thromboxane A2 receptor antagonist, S-1452, on postischemic brain injury in rats. 1993 Stroke pmid:8248988
Tohgi H et al. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin. 1988 Stroke pmid:3376161
Hagen AA et al. Synthesis of prostaglandins and thromboxane B2 by cerebral arteries. 1979 May-Jun Stroke pmid:462519
Patrono C et al. Thromboxane biosynthesis in cardiovascular diseases. 1990 Stroke pmid:2260137
Stier CT et al. Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. 1988 Stroke pmid:3413813
Koudstaal PJ et al. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. 1993 Stroke pmid:8421822
Chemtob S et al. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. 1990 Stroke pmid:2339458
Juvela S et al. Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. 1990 Stroke pmid:2396264
Tohgi H et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. 1992 Stroke pmid:1412574
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Chyatte D Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. 1989 Stroke pmid:2756534
Pettigrew LC et al. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. 1989 Stroke pmid:2718203
Vicari AM et al. Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks. 1987 Sep-Oct Stroke pmid:2957821
Bruno A et al. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. 2002 Stroke pmid:11779889
Cox D et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. 2006 Stroke pmid:16794200
Hanamura T et al. Prostaglandin profiles in relation to local circulatory changes following focal cerebral ischemia in cats. 1989 Stroke pmid:2728049
Shohami E et al. The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. 1982 Jul-Aug Stroke pmid:6896589
Jacobs TP et al. Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. 1987 Jul-Aug Stroke pmid:3603601
Grice SC et al. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. 1987 Jul-Aug Stroke pmid:3603606
Nagatsuka K et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin. 1985 Sep-Oct Stroke pmid:3931302
Numminen H et al. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. 2000 Stroke pmid:10835443
van Kooten F et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. 1999 Stroke pmid:10066850
Fujimoto T et al. Cerebrovascular injuries induced by activation of platelets in vivo. 1985 Mar-Apr Stroke pmid:3975962
Lee TK et al. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit. 1988 Stroke pmid:3363589
Vinge E et al. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. 1988 Stroke pmid:3363601
van Kooten F et al. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. 1997 Stroke pmid:9259748
Simeoni S et al. Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. 2011 Stress pmid:21434833
Sinzinger H et al. [Prostacyclin- and thromboxane synthesis in the vascular wall after gammatron irradiation]. 1986 Strahlenther Onkol pmid:3532388
Resnick DK et al. Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. 2001 Nov-Dec Spine J pmid:14588301
Resnick DK et al. Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury. 2001 Nov-Dec Spine J pmid:14588302
Nygaard OP et al. The inflammatory properties of contained and noncontained lumbar disc herniation. 1997 Spine pmid:9383853
Ikata T et al. Clinical considerations and biochemical basis of prognosis of cervical spinal cord injury. 1989 Spine pmid:2588059
Li F et al. [Effects of frostbite on some factors of blood coagulation system in rats under hypoxia]. 1996 Space Med Med Eng (Beijing) pmid:11539914
Chen TL et al. [Effects of fast decompression on prostaglandins content in cerebral tissue of guinea pigs]. 2002 Space Med Med Eng (Beijing) pmid:12222577
Chantharaksri U et al. Pathogenesis of hypoxemia. 1992 Southeast Asian J. Trop. Med. Public Health pmid:1298990
Bai L et al. [Effects of electro-acupuncture at Zusanli point on gastric and intestinal blood flow in rats with acute necrotizing pancreatitis]. 2013 Sichuan Da Xue Xue Bao Yi Xue Ban pmid:24490517
Kruse-Elliott KT et al. Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. 1998 Shock pmid:9466472
Kruse-Elliott KT et al. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. 1996 Shock pmid:8721386
Yanase T et al. Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. 1996 Shock pmid:8721389
Ploner F et al. Effects of combined selective iNOS inhibition and peroxynitrite blockade during endotoxemia in pigs. 2001 Shock pmid:11508865
Szebeni J et al. Complement activation during hemorrhagic shock and resuscitation in swine. 2003 Shock pmid:14501949
Wen SH et al. Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation. 2012 Shock pmid:22777122
Heller AR et al. Clusterin protects the lung from leukocyte-induced injury. 2003 Shock pmid:12865662
Yokoyama Y et al. Up-regulated thromboxane production in the rat liver with biliary obstruction does not contribute to promote hepatic injury. 2008 Shock pmid:17885643
Peck OM et al. The phosphatidylinositol 3 kinase pathway regulates tolerance to lipopolysaccharide and priming responses to Staphylococcus aureus and lipopolysaccharide. 2006 Shock pmid:16783195
LaNoue JL et al. Alveolar macrophage response to remote organ injury. 1998 Shock pmid:9565254
Darien BJ et al. Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. 1998 Shock pmid:9565256
Noda H et al. Left ventricular dysfunction and acute lung injury induced by continuous administration of endotoxin in sheep. 1994 Shock pmid:7735964
Chen H et al. Endotoxin tolerance: effects on lethality and macrophage thromboxane (B2) and interleukin 6 production. 1994 Shock pmid:7743340
Wollert PS et al. Prior exposure to endotoxin exacerbates lipopolysaccharide-induced hypoxemia and alveolitis in anesthetized swine. 1994 Shock pmid:7743363
Heller A et al. The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits. 2000 Shock pmid:10774617
Whiteford M et al. Effect of liposome-encapsulated hemoglobin on the development of endotoxin-induced shock in the rat. 1998 Shock pmid:9645495
Koch T et al. Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung. 1994 Shock pmid:7538430
Bellou A et al. Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock. 2003 Shock pmid:12558148
Li JX et al. Effects of cholinergic blockade on hemodynamic disturbances and intestinal lesions in endotoxic shock in newborn piglets. 1994 Shock pmid:7728588
Guyton K et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. 2003 Shock pmid:12813370
Klosterhalfen B et al. The influence of heat shock protein 70 induction on hemodynamic variables in a porcine model of recurrent endotoxemia. 1997 Shock pmid:9165671
Mayer AM et al. Escherichia coli lipopolysaccharide potentiation and inhibition of rat neonatal microglia superoxide anion generation: correlation with prior lactic dehydrogenase, nitric oxide, tumor necrosis factor-alpha, thromboxane B2, and metalloprotease release. 1999 Shock pmid:10188770
McCann ME et al. Effect of intravenous infusion of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro. 2000 Shock pmid:10947170
Zeltsman D et al. Pathophysiologic plasma levels of leukotriene C4 in relation to the hemodynamic dysfunction and mediator release of graded bacteremia. 1997 Shock pmid:9110414
Al-Salam Z et al. The effect of dobutamine on platelet aggregatory function in newborn piglets with hypoxia and reoxygenation. 2008 Shock pmid:18323735
Cochran JB et al. Age-related mortality and adherent splenic cell mediator production to endotoxin in the rat. 1995 Shock pmid:8608403
Melton SM et al. Mediator-dependent secondary injury after unilateral blunt thoracic trauma. 1999 Shock pmid:10454828
Quinn JV et al. Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. 1996 Shock pmid:8856849
Ogura S et al. Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria. 1999 Shock pmid:10446890
Tran HS et al. The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. 2000 Shock pmid:10847636
Reddoch KM et al. Hemostatic function of apheresis platelets stored at 4°C and 22°C. 2014 Shock pmid:24169210
Iwasaki W et al. Changes in the fatty acid composition of the liver with the administration of N-3 polyunsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver. 2010 Shock pmid:19543146
Wagner RS et al. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. 1996 Shock pmid:8821102
Peck OM et al. Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. 2004 Shock pmid:14770039
He B et al. [Effect of salt-loading on prostacyclin and thromboxane metabolism in kidney]. 1991 Sheng Li Xue Bao pmid:1754905
Zhao ZQ et al. [Effect of cardiac sympathetic nerves on changes of TXB2 and 6-keto-PGF1 alpha in venous blood of ischemic myocardium]. 1989 Sheng Li Xue Bao pmid:2762830
Hu DH [Effects of taurine enhancement of synthesis of TxA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells under acute hypoxia]. 1998 Sheng Li Xue Bao pmid:11324559
Hu DH et al. [Effects of hypoxia and anisodamine on products of TXA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells]. 1997 Sheng Li Xue Bao pmid:9863190
Yan GT et al. [Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation]. 1995 Sheng Li Xue Bao pmid:8762444
Li HP et al. [The relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure]. 1997 Sheng Li Xue Bao pmid:9863193
Zhang M et al. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril]. 1995 Sheng Li Xue Bao pmid:8762446
Ulutin ON Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions. 1988 Semin. Thromb. Hemost. pmid:2848323
Messmore HL et al. Molecular markers of platelet activation. 1984 Semin. Thromb. Hemost. pmid:6240115
Haubelt H et al. Can platelet function tests predict the clinical efficacy of aspirin? 2005 Semin. Thromb. Hemost. pmid:16149017
Abbate R et al. Defibrotide reduces monocyte PAI-2 and procoagulant activity. 1995 Semin. Thromb. Hemost. pmid:7660147
Coppola A et al. Homocysteine, coagulation, platelet function, and thrombosis. 2000 Semin. Thromb. Hemost. pmid:11011842
Fareed J et al. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition. 1986 Semin. Thromb. Hemost. pmid:2943019
Fareed J et al. Molecular markers of contrast media-induced adverse reactions. 1984 Semin. Thromb. Hemost. pmid:6393351
Brace LD and Fareed J An objective assessment of the interaction of heparin and its fractions with human platelets. 1985 Semin. Thromb. Hemost. pmid:4035366
Challis JR and Patrick JE The production of prostaglandins and thromboxanes in the feto-placental unit and their effects on the developing fetus. 1980 Semin. Perinatol. pmid:6992278
Cassin S Role of prostaglandins, thromboxanes, and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. 1987 Semin. Perinatol. pmid:3551084
Schick BP and Schick PK Megakaryocyte biochemistry. 1986 Semin. Hematol. pmid:2935939
Vignon E et al. Effects of tiaprofenic acid on interleukin 1, phospholipase A2 activity, prostaglandins, neutral protease, and collagenase activity in rheumatoid synovial fluid. 1989 Semin. Arthritis Rheum. pmid:2544031
Fenner H Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. 1997 Semin. Arthritis Rheum. pmid:9219317
Katsumata M et al. Diphenylhydantoin: an alternative ligand of a glucocorticoid receptor affecting prostaglandin generation in A/J mice. 1982 Science pmid:6897299
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Michelassi F et al. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. 1982 Science pmid:6808665
Kalaitzis C et al. Role of eicosanoids of the contralateral kidney in maintenance of two-kidney, one-clip renovascular hypertension in rats. 2007 Scand. J. Urol. Nephrol. pmid:17853043
Kalaitzis C et al. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats. 2005 Scand. J. Urol. Nephrol. pmid:15764265
Spence JD The arthritic patient with hypertension: selection of an NSAID. 1986 Scand. J. Rheumatol. Suppl. pmid:3541167
Trang LE et al. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. 1977 Scand. J. Rheumatol. pmid:929121
Chiricolo M et al. Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E. 1989 Scand. J. Immunol. pmid:2789430
Maddox Y et al. A routine source of human peritoneal macrophages. 1984 Scand. J. Immunol. pmid:6701470
Rainsford KD et al. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake. 1984 Scand. J. Gastroenterol. Suppl. pmid:6443622